{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:10:08Z","timestamp":1794013808919,"version":"4.8.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.anai.2023.09.009","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:53:22Z","timestamp":1695606802000},"page":"187-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Filaggrin and beyond"],"prefix":"10.1016","volume":"132","author":[{"given":"Nicholas","family":"Stefanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.anai.2023.09.009_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0002","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/all.13320","article-title":"The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies","volume":"73","author":"Abuabara","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0003","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0004","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40257-018-0383-4","article-title":"Major comorbidities of atopic dermatitis: beyond allergic disorders","volume":"19","author":"Paller","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"Silverberg","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/all.13946","article-title":"The exposome in atopic dermatitis","volume":"75","author":"Stefanovic","year":"2020","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0008","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaip.2023.02.005","article-title":"Targeting skin barrier function in atopic dermatitis","volume":"11","author":"van den Bogaard","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4168\/aair.2012.4.1.12","article-title":"Epidermal barrier in atopic dermatitis","volume":"4","author":"Kim","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.06.005","article-title":"The structure and function of the stratum corneum","volume":"435","author":"Menon","year":"2012","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0011","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbalip.2013.09.011","article-title":"Formation and functions of the corneocyte lipid envelope (CLE)","volume":"1841","author":"Elias","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2017.10.002","article-title":"Barrier dysfunction in the skin allergy","volume":"67","author":"Egawa","year":"2018","journal-title":"Allergol Int"},{"issue":"8","key":"10.1016\/j.anai.2023.09.009_bib0013","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/jid.2012.177","article-title":"Lamellar bodies: the key to cutaneous barrier function","volume":"132","author":"Feingold","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00441-012-1501-x","article-title":"Stratum corneum proteases and dry skin conditions","volume":"351","author":"Rawlings","year":"2013","journal-title":"Cell Tissue Res"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jid.2019.11.007","article-title":"Netherton syndrome: insights into pathogenesis and clinical implications","volume":"140","author":"Chiticariu","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010368","article-title":"Multiscale modelling of desquamation in the interfollicular epidermis","volume":"18","author":"Miller","year":"2022","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0017","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anai.2019.10.008","article-title":"The role of filaggrin in atopic dermatitis and allergic disease","volume":"124","author":"Drislane","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0018","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/sj.jid.5700365","article-title":"Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis","volume":"126","author":"Irvine","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0019","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: filaggrin","volume":"132","author":"Brown","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.anai.2023.09.009_bib0020","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1398-9995.2010.02540.x","article-title":"Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity","volume":"66","author":"Kezic","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jdv.17787","article-title":"Natural moisturizing factors in children with and without eczema: associations with lifestyle and genetic factors","volume":"36","author":"Basu","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0022","first-page":"431","article-title":"Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis","volume":"179","author":"McAleer","year":"2018","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0023","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.anai.2023.09.009_bib0024","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jid.2018.01.029","article-title":"Uncommon filaggrin variants are associated with persistent atopic dermatitis in African Americans","volume":"138","author":"Margolis","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0025","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1038\/s41598-020-59627-7","article-title":"Correlation of age-of-onset of atopic dermatitis with filaggrin loss-of-function variant status","volume":"10","author":"Smieszek","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.anai.2023.09.009_bib0026","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.jid.2018.05.013","article-title":"Exome sequencing and rare variant analysis reveals multiple filaggrin mutations in Bangladeshi families with atopic eczema and additional risk genes","volume":"138","author":"Pigors","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0027","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng2020","article-title":"Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema","volume":"39","author":"Sandilands","year":"2007","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0028","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/ijd.15887","article-title":"Prevalence of filaggrin loss-of-function variants in Chilean population with and without atopic dermatitis","volume":"61","author":"C\u00e1rdenas","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.anai.2023.09.009_bib0029","doi-asserted-by":"crossref","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Wang Q, Alf\u00f6ldi J, et al. A genome-wide mutational constraint map quantified from variation in 76,156 human genomes. bioRxiv. Available at: https:\/\/www.biorxiv.org\/content\/10.1101\/2022.03.20.485034v2. Accessed July 22, 2023.","DOI":"10.1038\/s41586-023-06045-0"},{"issue":"11","key":"10.1016\/j.anai.2023.09.009_bib0030","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jamadermatol.2019.1946","article-title":"Association of filaggrin loss-of-function variants with race in children with atopic dermatitis","volume":"155","author":"Margolis","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0031","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.12.646","article-title":"Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis","volume":"119","author":"Nomura","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0032","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1398-9995.2010.02493.x","article-title":"Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0033","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2133.2011.10331.x","article-title":"Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0034","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2133.2009.09112.x","article-title":"Analysis of Taiwanese ichthyosis vulgaris families further demonstrates differences in FLG mutations between European and Asian populations","volume":"161","author":"Hsu","year":"2009","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.009_bib0035","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/all.12049","article-title":"Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0036","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1365-2133.2011.10475.x","article-title":"Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis","volume":"165","author":"Winge","year":"2011","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.009_bib0037","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/ijd.14213","article-title":"Filaggrin gene polymorphisms in Iranian ichthyosis vulgaris and atopic dermatitis patients","volume":"57","author":"Hassani","year":"2018","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0038","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2013.09.053","article-title":"South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin","volume":"133","author":"Thawer-Esmail","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0039","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/jid.2011.342","article-title":"Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect","volume":"132","author":"Brown","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"10","key":"10.1016\/j.anai.2023.09.009_bib0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41576-020-0236-x","article-title":"Long-read human genome sequencing and its applications","volume":"21","author":"Logsdon","year":"2020","journal-title":"Nat Rev Genet"},{"issue":"8","key":"10.1016\/j.anai.2023.09.009_bib0041","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jid.2023.02.021","article-title":"Investigations into the FLG null phenotype: showcasing the methodology for CRISPR\/Cas9 editing of human keratinocytes","volume":"143","author":"Smits","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0042","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2133.2007.07999.x","article-title":"On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis","volume":"157","author":"Hoffjan","year":"2007","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.009_bib0043","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.biochi.2011.05.028","article-title":"S100 and S100 fused-type protein families in epidermal maturation with special focus on S100A3 in mammalian hair cuticles","volume":"93","author":"Kizawa","year":"2011","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.anai.2023.09.009_bib0044","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0625.2012.01472.x","article-title":"The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the \u2018fused genes\u2019 family","volume":"21","author":"Kypriotou","year":"2012","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaci.2022.11.008","article-title":"Epidermal differentiation complex genetic variation in atopic dermatitis and peanut allergy","volume":"151","author":"Huffaker","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2023.09.009_bib0046","doi-asserted-by":"crossref","unstructured":"Makino T, Mizawa M, Takemoto K, Yamamoto S, Shimizu T. Altered expression of S100 fused-type proteins in an atopic dermatitis skin model [e-pub ahead of print]. Exp Dermatol. https:\/\/doi.org\/10.1111\/exd.14797. Accessed July 22, 2023.","DOI":"10.1111\/exd.14797"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0047","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jaci.2012.12.1566","article-title":"Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin","volume":"131","author":"Pellerin","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.09.009_bib0048","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00403-021-02319-7","article-title":"Uncommon variants in FLG2 and TCHHL1 are associated with remission of atopic dermatitis in a large longitudinal US cohort","volume":"314","author":"Berna","year":"2022","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0049","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaci.2013.09.015","article-title":"Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects","volume":"133","author":"Margolis","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.abd.2019.07.002","article-title":"Analysis of filaggrin 2 gene polymorphisms in patients with atopic dermatitis","volume":"95","author":"Hertz","year":"2020","journal-title":"An Bras Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0051","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1038\/s41598-019-39219-w","article-title":"Cationic intrinsically disordered antimicrobial peptides (CIDAMPs) represent a new paradigm of innate defense with a potential for novel anti-infectives","volume":"9","author":"Latendorf","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0052","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1038\/s41598-018-34467-8","article-title":"Hornerin contains a linked series of ribosome-targeting peptide antibiotics","volume":"8","author":"Gerstel","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.anai.2023.09.009_bib0053","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jid.2023.01.022","article-title":"CYSRT1: an antimicrobial epidermal protein that can interact with late cornified envelope proteins","volume":"143","author":"Niehues","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0054","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.09.009_bib0055","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: from biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0056","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.0022-202x.2001.01401.x","article-title":"Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin","volume":"117","author":"Ali","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0057","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaci.2007.01.044","article-title":"Antiviral activity of human beta-defensin 3 against vaccinia virus","volume":"119","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0058","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cei.13013","article-title":"Current insights into the role of human \u03b2-defensins in atopic dermatitis","volume":"190","author":"Chieosilapatham","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.anai.2023.09.009_bib0059","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1111\/all.14762","article-title":"Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum","volume":"76","author":"Bin","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2023.09.009_bib0060","unstructured":"Budu-Aggrey A, Kilanowski A, Sobczyk MK, Shringarpure SS, Mitchell R, Reis K, et al. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation. medRxiv. Available at:https:\/\/www.medrxiv.org\/content\/10.1101\/2022.10.05.22279072v1. Accessed July 29, 2023."},{"key":"10.1016\/j.anai.2023.09.009_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.876515","article-title":"Alarmin cytokines as central regulators of cutaneous immunity","volume":"13","author":"Hasegawa","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0062","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaci.2010.08.041","article-title":"Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression","volume":"126","author":"Oyoshi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0063","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2011.12.989","article-title":"Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency","volume":"129","author":"Kezic","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/bjd.15010","article-title":"Atopic dermatitis is associated with reduced corneodesmosin expression: role of cytokine modulation and effects on viral penetration","volume":"176","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0066","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/exd.12047","article-title":"The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis","volume":"22","author":"Hatano","year":"2013","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0067","doi-asserted-by":"crossref","first-page":"e98006","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"3","author":"Berdyshev","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0068","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jid.2020.07.017","article-title":"The multiple roles of urocanic acid in health and disease","volume":"141","author":"Hart","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0069","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2023.02.013","article-title":"Stratum corneum lipid and cytokine biomarkers at age 2 months predict the future onset of atopic dermatitis","volume":"151","author":"Berdyshev","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2012.07.004","article-title":"Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis","volume":"68","author":"Sawada","year":"2012","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0071","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2017.05.005","article-title":"Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition","volume":"88","author":"Danso","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0072","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jdv.15973","article-title":"Neuroimmune interactions in chronic itch of atopic dermatitis","volume":"34","author":"Yosipovitch","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0073","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2023.03.013","article-title":"Neuroimmune interactions in atopic and allergic contact dermatitis","volume":"151","author":"Liu","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"10.1016\/j.anai.2023.09.009_bib0074","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.1073\/pnas.1002601107","article-title":"Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns","volume":"107","author":"Dominguez-Bello","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0075","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/bjd.15390","article-title":"The role of the skin microbiome in atopic dermatitis: a systematic review","volume":"177","author":"Bjerre","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0076","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0077","article-title":"Infant mode of delivery shapes the skin mycobiome of prepubescent children","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.anai.2023.09.009_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1114321","article-title":"Head and neck dermatitis is exacerbated by Malassezia furfur colonization, skin barrier disruption, and immune dysregulation","volume":"14","author":"Chu","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.anai.2023.09.009_bib0079","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.3390\/ijms24076171","article-title":"Interactions between Malassezia and new therapeutic agents in atopic dermatitis affecting skin barrier and inflammation in recombinant human epidermis model","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/jcm4061217","article-title":"The role of Malassezia spp. in atopic dermatitis","volume":"4","author":"Glatz","year":"2015","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0081","doi-asserted-by":"crossref","first-page":"AB181","DOI":"10.1016\/j.jaci.2021.12.597","article-title":"Sensitization to Malassezia sympodialis is associated with low efficacy of local anti-inflammatory therapy in patients with contact dermatitis","volume":"149","author":"Litus","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0082","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4168\/aair.2019.11.5.593","article-title":"Interactions between atopic dermatitis and Staphylococcus aureus infection: clinical implications","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0083","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014444118","article-title":"Staphylococcus aureus binds to the N-terminal region of corneodesmosin to adhere to the stratum corneum in atopic dermatitis","volume":"118","author":"Towell","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0084","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01184-18","article-title":"Adhesion of Staphylococcus aureus to corneocytes from atopic dermatitis patients is controlled by natural moisturizing factor levels","volume":"9","author":"Feuillie","year":"2018","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002751","article-title":"Crystal structures reveal the multi-ligand binding mechanism of Staphylococcus aureus ClfB","volume":"8","author":"Xiang","year":"2012","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.anai.2023.09.009_bib0086","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/jid.2014.43","article-title":"Th2 cytokines increase Staphylococcus aureus alpha toxin induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6)","volume":"134","author":"Brauweiler","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0087","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/toxins11060321","article-title":"Exploring the role of Staphylococcus aureus toxins in atopic dermatitis","volume":"11","author":"Yoshikawa","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0088","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/all.15640","article-title":"Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction","volume":"78","author":"Kim","year":"2023","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0089","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and atopic dermatitis: a Complex and Evolving Relationship","volume":"26","author":"Geoghegan","year":"2018","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0090","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/all.14489","article-title":"Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort","volume":"76","author":"Gonzalez","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0091","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068395","article-title":"Defining the temporal relationship between the skin microbiome, immune response and skin barrier function during flare and resolution of atopic dermatitis: protocol of a Danish intervention study","volume":"13","author":"R\u00f8nnstad","year":"2023","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.anai.2023.09.009_bib0092","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.jid.2023.03.1682","article-title":"Reduced skin microbiome diversity in infancy is associated with increased risk of atopic dermatitis in high-risk children","volume":"143","author":"Halling","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0093","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3390\/nu13051682","article-title":"A combined analysis of gut and skin microbiota in infants with food allergy and atopic dermatitis: a pilot study","volume":"13","author":"\u0141o\u015b-Rycharska","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.anai.2023.09.009_bib0094","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/all.15671","article-title":"The skin microbiome in the first year of life and its association with atopic dermatitis","volume":"78","author":"Rapin","year":"2023","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40521-021-00289-9","article-title":"The role of the environment and exposome in atopic dermatitis","volume":"8","author":"Stefanovic","year":"2021","journal-title":"Curr Treat Options Allergy"},{"issue":"10","key":"10.1016\/j.anai.2023.09.009_bib0096","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/jdv.15023","article-title":"The effects of season and weather on healthcare utilization among patients with atopic dermatitis","volume":"32","author":"Hamann","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0097","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/ijd.14289","article-title":"Atopic dermatitis: the relationship to temperature and seasonality in the United States","volume":"58","author":"Fleischer","year":"2019","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0098","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jdermsci.2017.02.280","article-title":"Lowering relative humidity level increases epidermal protein deimination and drives human filaggrin breakdown","volume":"86","author":"Cau","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0099","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jdv.13301","article-title":"The effect of environmental humidity and temperature on skin barrier function and dermatitis","volume":"30","author":"Engebretsen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.anai.2023.08.007","article-title":"The impact of temperature on the skin barrier and atopic dermatitis","volume":"131","author":"Hui-Beckman","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0101","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2022.01.027","article-title":"Transient receptor potential vanilloid 1 plays a major role in low temperature-mediated skin barrier dysfunction","volume":"150","author":"Kim","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0102","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/jcm11020298","article-title":"Impact of water exposure and temperature changes on skin barrier function","volume":"11","author":"Herrero-Fernandez","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0103","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.jdermsci.2016.08.203","article-title":"Effect of cis-urocanic acid on atopic dermatitis in NC\/Nga mice","volume":"84","author":"Rieko","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"12","key":"10.1016\/j.anai.2023.09.009_bib0104","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1038\/jid.2008.169","article-title":"Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement","volume":"128","author":"Hong","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145185","article-title":"Particulate matter causes skin barrier dysfunction","volume":"6","author":"Kim","year":"2021","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0106","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaad.2021.05.061","article-title":"Exposure to air pollution and incidence of atopic dermatitis in the general population: a national population-based retrospective cohort study","volume":"87","author":"Park","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0107","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12940-020-0563-6","article-title":"Association between exposure to traffic-related air pollution and pediatric allergic diseases based on modeled air pollution concentrations and traffic measures in Seoul, Korea: a comparative analysis","volume":"19","author":"Min","year":"2020","journal-title":"Environ Health"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0108","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/sj.jid.5701170","article-title":"Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo","volume":"128","author":"T\u00f6rm\u00e4","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0109","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cea.14071","article-title":"Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial)","volume":"52","author":"Jabbar-Lopez","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"10.1016\/j.anai.2023.09.009_bib0110","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s40265-022-01722-2","article-title":"New topical therapies in development for atopic dermatitis","volume":"82","author":"Freitas","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-021-00266-6","article-title":"Atopic dermatitis: an expanding therapeutic pipeline for a complex disease","volume":"21","author":"Bieber","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0112","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/ced.15141","article-title":"Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis","volume":"47","author":"Danby","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.09.009_bib0113","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.anai.2022.01.012","article-title":"Optimizing emollient therapy for skin barrier repair in atopic dermatitis","volume":"128","author":"Elias","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10228","key":"10.1016\/j.anai.2023.09.009_bib0114","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(19)32984-8","article-title":"Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial","volume":"395","author":"Chalmers","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0115","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/all.15491","article-title":"Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants\u2014the STOP-AD randomised controlled trial","volume":"78","author":"N\u00ed Chaoimh","year":"2023","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0116","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjd.19703","article-title":"Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis","volume":"185","author":"McAleer","year":"2021","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2023.09.009_bib0117","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jocd.14685","article-title":"Emerging topical drug delivery approaches for the treatment of atopic dermatitis","volume":"21","author":"Ghosalkar","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.anai.2023.09.009_bib0118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.620098","article-title":"Ruxolitinib cream has dual efficacy on pruritus and inflammation in experimental dermatitis","volume":"11","author":"Scuron","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0119","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2021.04.085","article-title":"Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double-blind studies","volume":"85","author":"Papp","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2023.09.009_bib0120","doi-asserted-by":"crossref","unstructured":"Simpson EL, Schlievert PM, Yoshida T, Lussier S, Boguniewicz M, Hata T, et al. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment [e-pub ahead of print]. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2023.05.026, accessed July 29, 2023.","DOI":"10.1016\/j.jaci.2023.05.026"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0121","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaad.2022.11.047","article-title":"Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial","volume":"88","author":"Beck","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.009_bib0122","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jid.2016.07.027","article-title":"TSLP down-regulates S100A7 and \u00df-defensin 2 via the JAK2\/STAT3-dependent mechanism","volume":"136","author":"Lee","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anai.2023.09.009_bib0123","doi-asserted-by":"crossref","unstructured":"Facheris P, Jeffery J, Del Duca E, Guttman-Yassky E. The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment [e-pub ahead of print]. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-023-00992-4, accessed July 29, 2023.","DOI":"10.1038\/s41423-023-00992-4"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0124","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jdv.18925","article-title":"Tapinarof for psoriasis and atopic dermatitis: 15\u2009years of clinical research","volume":"37","author":"Bissonnette","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.anai.2023.09.009_bib0125","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.3390\/jcm11123341","article-title":"Dupilumab improves skin barrier function in adults with atopic dermatitis: a prospective observational study","volume":"11","author":"Montero-Vilchez","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.anai.2023.09.009_bib0126","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1111\/all.15432","article-title":"Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis","volume":"77","author":"Berdyshev","year":"2022","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.09.009_bib0127","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2014.03.003","article-title":"Cyclosporine A in atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology","volume":"133","author":"Khattri","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.09.009_bib0128","doi-asserted-by":"crossref","first-page":"adv00447","DOI":"10.2340\/00015555-3810","article-title":"Skin barrier and inflammation genes associated with atopic dermatitis are regulated by interleukin-13 and modulated by tralokinumab in vitro","volume":"101","author":"Tollenaere","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.anai.2023.09.009_bib0129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2015.03.051","article-title":"The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling","volume":"136","author":"Amano","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.alit.2021.10.004","article-title":"Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors","volume":"71","author":"Nakashima","year":"2022","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.anai.2023.09.009_bib0131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623012656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623012656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:33:54Z","timestamp":1761053634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623012656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1081120623012656"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.09.009","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Filaggrin and beyond","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}